Catalyst Pharmaceuticals Inc.

(CPRX) Trade

By |

Profile

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome.

Contact Information

Website: www.catalystpharma.com
Email: pmcenany@catalystpharma.com
Main Phone: +1 305 420-3200
Address: 355 Alhambra Circle
Address 2: Suite 1250
State: FL
City / Town: Coral Gables
Country: US
Postal Code: 33134

Issuer Information

Exchange: NSC
CEO: Patrick J. McEnany
Employees: 76
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome.

Contact Information

Website: www.catalystpharma.com
Email: pmcenany@catalystpharma.com
Main Phone: +1 305 420-3200
Address: 355 Alhambra Circle
Address 2: Suite 1250
State: FL
City / Town: Coral Gables
Country: US
Postal Code: 33134

Issuer Information

Exchange: NSC
CEO: Patrick J. McEnany
Employees: 76
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 3.16 $ 0.085 (2.76%)
Last Price 3.16 Change $ 0.085 Change % 2.76 Tick N/A
Bid 3.05 Bid Size 400.00 Ask 3.16 Ask Size 5,000.00
Open 3.06 High 3.20 Low 3.06 Prev Close 3.08
Last Trade Volume 901,510 52 Wk Hi 5.83 52 Wk Low 2.55
Market Cap 326.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 103,463,460.00 EPS (TTM) 0.39 PE Ratio 8.10 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 46
Number of Buys 8 38
Number of Sells 0 8
Net Activity 565000 1950947
Last 10 Buys Shares
Donald A. Denkhaus 1,000
Charles B. O'Keeffe 1,000
Charles B. O'Keeffe 1,000
Donald A. Denkhaus 1,000
Patrick J. McEnany 1,000
Patrick J. McEnany 1,000
Charles B. O'Keeffe 1,000
Philip H. Coelho 1,000
Philip H. Coelho 1,000
Donald A. Denkhaus 1,000
Last 10 Sell Shares
M. Douglas Winship 1,000
Philip H. Coelho 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 7.33 7.33 7.33 7.33
Standard Deviation 2.31 2.31 2.31 2.31
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1